39 Relevance of the ischemia trial to real-world clinical services

Abstract

control group which was not significantly different (mean difference = 2.4 days, 95% CI = -0.5, 5.3 days, p = 0.1). Conclusion UACDT is a safe procedure and although there is no difference in LOS with the procedure there is a potential that this difference will become more important as confidence with the procedure increases. There is a 12% incidence of occult cancer in this group of patients.